You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》康德莱医械(01501.HK)暗盘收报25.75元 高上市价23.8%
阿思达克 11-07 18:33

根据辉立交易平台显示,明天挂牌的康德莱医疗器械(01501.HK)暗盘高开逾16%报24.2元,最多涨24.8%高见25.95元,收报25.75元,较上市价20.8元,高23.8%或4.95元,成交402万股,涉资1.01亿元。不计手续费,每手200股,账面赚990元。

康德莱是内地领先心内介入器械制造商,公司主要产品(包括球囊扩张压力泵、导管鞘套装、造影导丝、动脉压迫止血带、Y型连接器套装、压力延长管、三通旋塞及造影导管)主要用於心血管介入手术(特别是PCI手术)。根据弗若斯特沙利文,按2018年销售收入计,康德莱於内地PCI支援器械及冠状动脉介入器械市场的国产品牌中分别排名第一及第二。

是次来港上市共发售4,000万股H股,并已引入Worldwide Healthcare Trust及专注医疗保健投资的私募基金OrbiMed为基石投资者,合共认购1,131.28万股;其中10%公开发售获近267倍超购,已启动回拨机制占比增至50%,认购一手中签率30%;股份以招股范围(20.1-20.8元)上限定价,料集资净额7.58亿元,主要用作上海市嘉定区研发中心和额外生产设施、开发现有管线产品并将其商业化、购买额外生产设备并替换现有生产设备和将生产线自动化、扩大康德莱的分销网络和覆盖范围及为潜在战略投资提供资金等。上市独家保荐人交银国际。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account